All In Biotech

Drug Trial Radar · NCT03808922

Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study

A Phase III Randomized Placebo-Controlled Study to Examine the Efficacy and Safety of DAS181 for the Treatment of Lower Respiratory Tract Parainfluenza Infection in Immunocompromised Subjects

Last checked: Nov 19, 2026Latest source record: Jun 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 274 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

274

Planned (sponsor's estimate)

Start

May 23, 2019

Primary completion

Sep 1, 2028

Study completion Sep 1, 2028

Sponsor

Lead sponsor
Ansun Biopharma, Inc.Industry
Sponsor type
Industry
First posted
Jan 18, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will seek to enroll immunocompromised patients with Lower Tract parainfluenza infection. It also contains a sub-study to enroll patients with severe COVID-19.

Conditions

  • Lower Respiratory Tract Infection
  • Parainfluenza
  • Immunocompromised
  • COVID-19

Interventions

  • DAS181Drug

    DAS181 4.5mg nebulized qd x 7 OR 10 days

  • PlaceboDrug

    Placebo nebulized qd x 7 OR 10 days

  • DAS181 COVID-19Drug

    DAS181 4.5mg nebulized q12h/day x 7 OR 10 days

  • DAS181 OLDrug

    DAS181 4.5mg nebulized qd x 7 OR 10 days ≥ 40kg DAS181 2.5mg nebulized qd x 7 OR 10 days \< 40kg

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent of subjects who Return to Room Air (RTRA) (main study)Time frame: by Day 28
  2. Percent of subjects with improved COVID-19 Clinical Status Scale (sub-study)Time frame: Day 14

Locations

28 sites in 5 countries. Site status is shown where the registry gives one.

  • City of Hope cancer Center

    Duarte, California · Recruiting

  • University of California Davis Health System

    Sacramento, California · Recruiting

  • Ann & Robert H. Lurie Children's Hospital of Chicago

    Chicago, Illinois · Recruiting

  • University of Iowa Health Care

    Iowa City, Iowa · Recruiting

  • University of Kansas Medical Center

    Fairway, Kansas · Recruiting

  • The Johns Hopkins Hospital

    Baltimore, Maryland · Withdrawn

  • Brigham and Women's Hospital

    Boston, Massachusetts · Recruiting

  • Mayo Clinic Rochester

    Rochester, Minnesota · Recruiting

  • Washington University

    St Louis, Missouri · Withdrawn

  • Weill Cornell Medical College

    New York, New York · Recruiting

  • Duke University

    Durham, North Carolina · Recruiting

  • Cincinnati Children's Hospital Medical Center

    Cincinnati, Ohio · Recruiting

  • University of Oklahoma Health Sciences Center

    Oklahoma City, Oklahoma · Recruiting

  • Oregon Health & Science University

    Portland, Oregon · Withdrawn

  • University of Pittsburgh Medical Center Health System

    Pittsburgh, Pennsylvania · Recruiting

  • UT Southwestern Medical Center

    Dallas, Texas · Recruiting

  • Baylor College of Medicine

    Houston, Texas · Recruiting

  • MD Anderson

    Houston, Texas · Recruiting

  • VCU Health System

    Richmond, Virginia · Recruiting

  • Seattle Children's Hospital

    Seattle, Washington · Recruiting

  • Fred Hutchinson Cancer Center

    Seattle, Washington · Recruiting

  • Fred Hutchinson Cancer Research Center

    Seattle, Washington · Recruiting

  • Froedtert Medical College Pulmonary Clinic

    Milwaukee, Wisconsin · Completed

  • Westmead Hospital

    Sydney, New South Wales, Australia · Terminated

  • Shanghai Pulmonary Hospital

    Yangpu, Shanghai Municipality, China · Terminated

  • Seoul National University Hospital

    Seoul, Gyeonggi-do, South Korea · Terminated

  • Samsung Medical Center

    Seoul, Gyeonggi-do, South Korea · Terminated

  • National Cheng Kung University Hospital

    Tainan, Tainan, Taiwan · Terminated

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.